February 4, 2021

Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial

-Vaccines (Basel) 2020
September 17, 2020

Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization

Cancers 2020, 12(5), 1114; https://doi.org/10.3390/cancers12051114
September 17, 2020

Overview of multiplex immunohistochemistry / immunofluorescence techniques in the era of cancer immunotherapy

Cancer Communications. 2020;40:135–153. https://doi.org/10.1002/cac2.12023
September 17, 2020

Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment

Clin Cancer Res 2020;26:2640–53 https://doi.org/10.1158/1078-0432.CCR-19-3231
September 17, 2020

The coming 15 years in gynaecological pathology: digitisation, artificial intelligence, and new technologies

Histopathology 2020, 76, 171–177. https://doi.org/10.1111/his.13991
September 17, 2020

New Technologies to Image Tumors

(2020) New Technologies to Image Tumors. In: Lee P., Marincola F. (eds) Tumor Microenvironment. Cancer Treatment and Research, vol 180. Springer, Cham. https://doi.org/10.1007/978-3-030-38862-1_2
September 17, 2020

Multiplexed immunohistochemistry for immune cell phenotyping, quantification and spatial distribution in situ

Methods in Enzymology 2020; 635, 51-66 https://doi.org/10.1016/bs.mie.2019.10.002
September 17, 2020

Biomarkers for Immunotherapy of Cancer

(2020). Biomarkers for Immunotherapy of Cancer. Methods in Molecular Biology. doi:10.1007/978-1-4939-9773-2
September 30, 2020

PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer

-Clin. Cancer Research
Contact Us